Mobidiag Ltd today announced a distribution agreement with Interlux OÜ, supplier of technologies for medicine, science and biotechnology industry. Under this agreement, Interlux becomes the exclusive distributor of the Amplidiag® product line in Estonia, in vitro diagnostic tests and compatible instrument for the detection of gastrointestinal infections.
ESPOO, Finland, November 23rd, 2017 – Mobidiag Ltd. today announced a distribution agreement with Interlux OÜ, supplier of technologies for medicine, science and biotechnology industry. Under this agreement, Interlux becomes the exclusive distributor of the Amplidiag® product line in Estonia, in vitro diagnostic tests and compatible instrument for the detection of gastrointestinal infections.
“Thanks to a large distribution network, our Amplidiag product line is now accessible in most Western European countries. This new distribution agreement allows us to introduce the Amplidiag product line to the Baltic region starting with Estonia. We are then very happy to start this new partnership with Interlux to support us in this new market”, said Miquel Vernet, CCO at Mobidiag.
“Cooperation with Mobidiag offers the customers of Interlux high-quality diagnostic results. I believe that together with Mobidiag we can improve the medicine in Estonia and offer solutions to laboratories that will have greater effect on the patient”, said Karin Kõnd, CEO at Interlux OÜ.
The agreement is effective immediately and covers all Amplidiag IVD tests (Amplidiag H. pylori+ClariR, Amplidiag Stool Parasites, Amplidiag CarbaR+VRE, Amplidiag C. difficile+027, Amplidiag Bacterial GE, Amplidiag Viral GE and upcoming Amplidiag CarbaR+MCR) as well as the Amplidiag Easy instrument.